Neuronoff, Inc., a clinical-stage neuromodulation company, today announced successful chronic large animal demonstration of its IPG-compatible Injectrode® platform, in which a single remotely ...

LOS ANGELES, March 4, 2025 /PRNewswire/ — Nervonik, Inc. (Nervonik), a medical device company developing an opioid-free peripheral nerve stimulation (PNS) system, has successfully closed a $13 million ...

Please provide your email address to receive an email when new articles are posted on . Published results showed percutaneous peripheral nerve stimulation may provide clinically meaningful and ...

The American College of Radiology is supporting a call from 10 medical specialty societies and academies urging Cigna Healthcare and UnitedHealthcare to update their coverage policies for peripheral ...

CARLSBAD, Calif.--(BUSINESS WIRE)--Nalu Medical announces the FDA clearance for expanded labeling of its Peripheral Nerve Stimulation (PNS) System, now approved for whole-body MRI-conditional use.

CARLSBAD, Calif.--(BUSINESS WIRE)--Nalu Medical, Inc. (“Nalu”) a Carlsbad, California-based company that markets a minimally invasive neurostimulation implant for the management of chronic intractable ...

Shoulder pain is one of the most common locations of chronic pain. It impacts quality of life and has the potential to become disabling for millions of Americans. The 60-day SPR ® SPRINT ® Peripheral ...

POMPANO BEACH, Fla., March 27, 2025 (GLOBE NEWSWIRE) -- Curonix LLC, a leading medical technology company specializing in relieving chronic pain without the use of opioids, proudly introduces ...

SPR ®, a leading private medical device company focused on improving the lives of millions of people living with pain, announced that Aetna has published an updated medical policy that designates the ...

Please provide your email address to receive an email when new articles are posted on . The FDA cleared SPR Therapeutics’ Sprint Peripheral Nerve Stimulation system, which had been approved for the ...